SEC Form 4 · accession 0001708138-18-000009
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Roy Vagelos
Officer — Chairman of the Board · Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2018 | M | 153,274 | $16.80 | A | 553,121 | D | |
| Common Stock | Jun 20, 2018 | F | 78,564 | $333.07 | D | 474,557 | D | |
| Common StockF2 | Jun 21, 2018 | S | 400 | $323.97 | D | 474,157 | D | |
| Common StockF3 | Jun 21, 2018 | S | 500 | $324.18 | D | 473,657 | D | |
| Common StockF4 | Jun 21, 2018 | S | 8,047 | $325.67 | D | 465,610 | D | |
| Common StockF5 | Jun 21, 2018 | S | 15,594 | $326.57 | D | 450,016 | D | |
| Common StockF6 | Jun 21, 2018 | S | 19,393 | $327.48 | D | 430,623 | D | |
| Common StockF7 | Jun 21, 2018 | S | 12,426 | $328.45 | D | 418,197 | D | |
| Common StockF8 | Jun 21, 2018 | S | 12,854 | $329.51 | D | 405,343 | D | |
| Common StockF9 | Jun 21, 2018 | S | 3,096 | $330.32 | D | 402,247 | D | |
| Common Stock | Jun 21, 2018 | S | 100 | $331.09 | D | 402,147 | D | |
| Common StockF10 | Jun 21, 2018 | S | 1,300 | $332.80 | D | 400,847 | D | |
| Common StockF11 | Jun 21, 2018 | S | 500 | $333.15 | D | 400,347 | D | |
| Common StockF12 | Jun 21, 2018 | S | 300 | $335.01 | D | 400,047 | D | |
| Common Stock | Jun 21, 2018 | S | 200 | $336.87 | D | 399,847 | D | |
| Common Stock | Jan 2, 2018 | G | 557 | $0.00 | D | 149,160 | I | by CLAT |
| Common Stock | Apr 2, 2018 | G | 616 | $0.00 | D | 148,544 | I | by CLAT |
| Common Stock | holding | — | — | — | 2,310 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 83,652 | I | by Spouse as Trustee | |
| Common StockF13 | holding | — | — | — | 1,203 | I | by trust for grandch |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F14 | $16.80 | Jun 20, 2018 | M | 153,274 | D | — | Dec 17, 2018 | Common Stock | 153,274 | 153,274 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F10Represents volume-weighted average price of sales of 1,300 shares of Company stock on June 21, 2018 at prices ranging from $332.40 to $332.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F11Represents volume-weighted average price of sales of 500 shares of Company stock on June 21, 2018 at prices ranging from $333.01 to $333.28. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F12Represents volume-weighted average price of sales of 300 shares of Company stock on June 21, 2018 at prices ranging from $335.00 to $335.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F13By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
- F14The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F2Represents volume-weighted average price of sales of 400 shares of Company stock on June 21, 2018 at prices ranging from $323.96 to $323.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F3Represents volume-weighted average price of sales of 500 shares of Company stock on June 21, 2018 at prices ranging from $324.16 to $324.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F4Represents volume-weighted average price of sales of 8,047 shares of Company stock on June 21, 2018 at prices ranging from $325.05 to $325.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F5Represents volume-weighted average price of sales of 15,594 shares of Company stock on June 21, 2018 at prices ranging from $326.00 to $326.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F6Represents volume-weighted average price of sales of 19,393 shares of Company stock on June 21, 2018 at prices ranging from $327.00 to $327.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F7Represents volume-weighted average price of sales of 12,426 shares of Company stock on June 21, 2018 at prices ranging from $328.00 to $328.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F8Represents volume-weighted average price of sales of 12,854 shares of Company stock on June 21, 2018 at prices ranging from $329.00 to $329.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.
- F9Represents volume-weighted average price of sales of 3,096 shares of Company stock on June 21, 2018 at prices ranging from $330.00 to $330.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.